清醒镇静与全身麻醉在远端血管取栓术中的安全性与有效性
本研究基于2014年12月至2023年7月的前瞻性卒中登记,比较清醒镇静与全身麻醉在远端和中血管闭塞取栓中的效果。279例患者中,清醒镇静与更高的早期神经功能改善(OR 2.59)和成功再灌注(OR 2.33)相关,90天良好预后、出血并发症和死亡无显著差异。作者认为清醒镇静安全可行,但需进一步随机研究。
要点
- 清醒镇静与更高早期神经功能改善相关(OR 2.59,95%CI 1.04-6.98)。
- 清醒镇静与更高成功再灌注率相关(OR 2.33,95%CI 1.11-4.93)。
- 90天良好预后、脑出血、蛛网膜下腔出血和首过效应无差异。
核心结论
- 在远端和中血管闭塞取栓中,清醒镇静在成功再通、出血并发症、临床结局和死亡率方面似乎安全可行。
- 清醒镇静可能与更高的早期神经功能改善率相关。
- 作者认为需在该特定取栓亚组中进一步开展随机研究。
研究设计与样本
- 基于2014年12月至2023年7月前瞻性维护的卒中登记,纳入因急性缺血性卒中行血管内取栓的远端和中血管闭塞患者。
- 远端和中血管闭塞定义为M2、M3或M4闭塞;A1或A2闭塞;以及P1或P2闭塞。
- 比较接受清醒镇静的患者与接受全身麻醉的患者。
- 共279例患者,其中69例(24.7%)接受全身麻醉,193例(69.2%)接受清醒镇静。
主要发现
- 清醒镇静与更高的早期神经功能改善几率相关(OR 2.59,95% CI [1.04-6.98],P < .05)。
- 清醒镇静与更高的成功再灌注率相关(OR 2.33,95% CI [1.11-4.93],P < .05)。
- 清醒镇静与较低的死亡率呈非显著趋势(OR 0.51,95% CI [0.2-1.3],P = .16)。
- 90天良好预后、脑出血、蛛网膜下腔出血或首过效应方面未见差异。
临床怎么用
- 原文未据此给出推荐。
- 作者认为清醒镇静在血管内取栓中似乎安全可行,且可能与更高的早期神经功能改善率相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Anesthesia modality for endovascular thrombectomy (EVT) for distal and medium vessel occlusions remains an open question. General anesthesia (GA) may offer advantages over conscious sedation (CS) because of reduced patient movement facilitating catheter navigation, but concerns persist about potential delays and hypotension affecting collateral circulation. METHODS: In our prospectively maintained stroke registry from December 2014 to July 2023, we identified patients with distal and medium vessel occlusions defined as M2, M3, or M4 occlusion; A1 or A2 occlusion; and P1 or P2 occlusion, who underwent EVT for acute ischemic stroke. We compared patients who received CS with those who received GA. Primary outcomes were early neurological improvement (ENI), successful reperfusion, first-pass effect, and good outcome at 90 days. Secondary outcomes included intracerebral hemorrhage, subarachnoid hemorrhage, and 90-day mortality. RESULTS: Of 279 patients, 69 (24.7%) received GA, whereas 193 (69.2%) received CS. CS was associated with higher odds of ENI compared with GA (odds ratio [OR] 2.59, 95% CI [1.04-6.98], P < .05). CS was also associated with higher rates of successful reperfusion (OR 2.33, 95% CI [1.11-4.93], P < .05). CS nonsignificantly trended toward lower rates of mortality (OR 0.51, 95% CI [0.2-1.3], P = .16). No differences in good outcome at 90 days, intracerebral hemorrhage, subarachnoid hemorrhage, or first-pass effect were seen. CONCLUSION: The use of CS during EVT seems to be safe and feasible with regard to successful recanalization, hemorrhagic complications, clinical outcome, and mortality. In addition, it may be associated with a higher rate of ENI. Further randomized studies in this specific EVT subpopulation are warranted.
引用
- Mehta A, Reddi P, Goldman D, et al. Safety and Efficacy of Conscious Sedation Versus General Anesthesia for Distal Vessel Thrombectomy. Neurosurgery. 2024. PMID: 38856233. doi:10.1227/neu.0000000000003031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。